CELL DATA SCIENCES, INC.
Biotech · Acquired
Catalytic molecules and methods for removing formaldehyde adducts from DNA and RNA in formalin-fixed tissue specimens
- Grants
- $1.9M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens | $180,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens | $735,637 | |
| Federal grant | Department of Health and Human Services · Phase I · Reversible Reagents for Next-Gen Biomolecule and Tissue Preservation | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens | $730,394 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2488 | ANAVEX LIFE SCIENCES CORP. | — | $11M |
| 2489 | APPLIED GENETIC TECHNOLOGIES CORPORATION | — | $9.3M |
| 2490 | 3+2 PHARMA, LLC | — | — |
| 2491 | CELL DATA SCIENCES, INC. | — | — |
| 2492 | Cerevel Therapeutics | — | — |
| 2493 | BIOMARCK PHARMACEUTICALS, LTD | — | $8.0M |
| 2494 | AMYGDALA NEUROSCIENCES, INC. | — | $7.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Biomolecule Processing From Fixed Biological Samplesapplication
- Biomolecule Processing From Fixed Biological Samplesapplication
- Biomolecule Processing From Fixed Biological Samplesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.